Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 44,241 | 70,977 | 100,563 | 168,330 | 135,441 |
| Marketable Securities | 94 | 316 | 391 | N/A | 297 |
| Receivables | 216 | 10,089 | 7,602 | 4,359 | 2,702 |
| Inventories | 4,335 | 6,631 | 4,568 | 2,898 | N/A |
| Other current assets | 11,560 | 0 | 0 | 0 | 0 |
| TOTAL | $67,568 | $93,506 | $118,579 | $179,564 | $145,245 |
| Non-Current Assets | |||||
| PPE Net | 30,338 | 30,829 | 28,900 | 24,384 | 21,467 |
| Investments And Advances | 25,240 | 25,509 | 27,083 | 27,980 | 29,073 |
| Intangibles | 102,597 | 103,123 | 104,115 | 104,581 | 107,431 |
| Other Non-Current Assets | 335,132 | 334,076 | 330,797 | 287,578 | 284,748 |
| TOTAL | $493,307 | $493,537 | $490,895 | $444,523 | $442,719 |
| Total Assets | $560,875 | $587,043 | $609,474 | $624,087 | $587,964 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 25,877 | 32,257 | 8,678 | 10,150 | 28,231 |
| Accounts payable and accrued liabilities | 38,062 | 48,698 | 25,964 | 25,129 | 32,132 |
| Accrued Expenses | 33,143 | 17,383 | 33,749 | 23,639 | 21,106 |
| Other current liabilities | 9,000 | 7,900 | N/A | N/A | 309 |
| TOTAL | $112,713 | $111,989 | $74,082 | $61,621 | $82,410 |
| Non-Current Liabilities | |||||
| Long Term Debt | 234,370 | 223,589 | 229,662 | 223,136 | 145,535 |
| Deferred Revenues | 3,613 | 3,350 | 3,157 | 2,703 | 632 |
| Other Non-Current Liabilities | 94,503 | 87,817 | 101,344 | 10,081 | 8,986 |
| TOTAL | $441,493 | $420,438 | $417,279 | $354,966 | $281,994 |
| Total Liabilities | $554,206 | $532,427 | $491,361 | $416,587 | $364,404 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 141,871 | 130,979 | 122,551 | 122,280 | 122,274 |
| Common Shares | 13 | 13 | 13 | 13 | 13 |
| Retained earnings | -596,998 | -532,583 | -475,821 | -367,750 | -317,974 |
| Other shareholders' equity | -39,819 | -29,329 | -14,194 | -2,421 | 1,583 |
| TOTAL | $6,669 | $54,616 | $118,113 | $207,500 | $223,560 |
| Total Liabilities And Equity | $560,875 | $587,043 | $609,474 | $624,087 | $587,964 |